Development of Multifunctional Molecules as Potential Therapeutic


Aug 10, 2018 - Masha Savelieff began her science career in Chemistry at the American University of Beirut, Beirut, Lebanon, where she earned her B.S. ...
101 downloads 0 Views 11MB Size

Recommend Documents


ABSTRACT: Neurodegenerative diseases pose a substantial socioeconomic burden on ... development of multifunctional compounds capable of simultaneously ...

Development of Multifunctional Molecules as Potential Therapeutic ... Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, ... Parkinson,s disease (PD)2 and amyotrophic lateral sclerosis.

Aug 10, 2018 - Masha Savelieff began her science career in Chemistry at the American ... from Seoul National University of Science and Technology, Seoul, ...

Aug 10, 2018 - 60–80% of cases,(1) and other neurodegenerative diseases, including Parkinson's disease (PD)(2) and amyotrophic lateral sclerosis (ALS).

Although 63 had a lower brain to plasma ratio (0.63) in AGM relative to 61, it was ...... Walther , T.; Oliviera , S. M.; Pesquero , J. L.; Paiva , A. C. M.; Calixton , J. B.; ...

Jul 24, 2018 - Although demanding, the development of multifunctional theranostic nanoplatforms is attracting considerable worldwide interest. Herein, a ...

Jul 24, 2018 - Although demanding, the development of multifunctional theranostic ..... the Fundamental Research Funds for the Central Universities from ...

Apr 28, 2013 - (6, 10) In addition, they are potentially multifunctional, possessing an .... which means that it was approximately 17 times more potent than ...... Susumu , K.; Blessington , D.; Brannan , A. K.; Bates , F. S.; Chance ...... of Biomim

Two six-membered ring targeted analogues of PSMA inhibitors (4a and 4b) were designed on the basis of a computational analysis and synthesized.

Sep 2, 2009 - In many cases, without specific antimicrobial intervention, H. pylori infected individuals will develop type B gastritis, chronic peptic ulcers and, more rarely ... Here, we report the development of novel therapeutics that specifically